medigraphic.com
ISSN 1561-3070 (Electronic)

2022, Number 4

<< Back Next >>

Rev Cub Oftal 2022; 35 (4)

Ophthalmologic alterations in patients with COVID-19

Cáceres TM, Cáceres TO, Miranda PG, La O LY, Cordero CD

Language: Spanish
References: 25
Page: 1-15
PDF size: 333.14 Kb.


ABSTRACT

Introduction: Ophthalmologic alterations associated with SARS-CoV-2 can be classified as direct effects of the virus, by immunologic reaction or by vaccination.
Objective: To describe the ophthalmologic alterations in patients with COVID-19.
Methods: A series of cases with clinical and serologic diagnosis of COVID-19 during the course of the disease, after the disease or after vaccination is presented. Seven cases were studied (4 women and 3 men), who consecutively attended the Neurophthalmology Consultation of the "Hermanos Ameijeiras" Hospital (HHA), referred by specialists who evaluate the "Post-COVID-19" case protocol in this institution with the following alterations: neuroretinitis (NR), papillitis (P), uveitis and papillitis (U-P), epiretinal membrane (MER) and peripheral facial palsy (PFP), in the period from August to November 2021.
Results: The average age was 44 years. NR, P and unilateral MER predominated in the series studied. Immunologic etiology was the most frequent. The symptoms and signs referred by the patients were visual impairment and color vision deficit. Therapeutic results were not satisfactory in cases 1 and 6, with a prolonged evolution time, from the onset of symptoms to diagnosis and treatment with steroids and B-complex vitamins.
Conclusions: There is an association between the ophthalmologic diseases found in young patients with a history of suffering from COVID-19 or related to vaccination. Therapeutic effectiveness was conditioned by the time of evolution of the disease.


REFERENCES

  1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199-1207. DOI: http://dx.doi.org/10.1056/NEJMoa20013161.

  2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J. A novel coronavirus from patients with pneumonia in china, 2019. N Engl J Med. 2020;382:727-33. DOI: http://dx.doi.org/10.1056/NEJMoa20010172.

  3. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? The Lancet. 2020;395(10231):1225-28. DOI: http://dx.doi.org/10.1016/S0140-6736(20)30627-93.

  4. Sahin AR, Erdogan A, Mutlu Agaoglu P, Dineri Y, Cakirci A, Senel M, et al. Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature. Eurasian J Med Investig. 2020[acceso 24/03/2022];4(1):1-7. Disponible en: https://www.ejmo.org/10.14744/ejmo.2020.122204.

  5. Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020;395(10224). DOI: http://dx.doi.org/10.1016/S0140-6736(20)30313-55.

  6. Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science. 2020;67(6485):1444-8. DOI: http://dx.doi.org/10.1126/science.abb27626.

  7. Danesh-Meyer HV, McGhee CNJ. Implications of COVID-19 for Ophthalmologists. American Journal. 2020. DOI: http://dx.doi.org/10.1002/jmv.257257.

  8. Piloto Díaz I. Los efectos no estimados posCOVID-19. Rev Cubana Oftalmol [Internet]. 2020 [acceso 24/03/2022];33(2):e944. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21762020000200001&lng=es8.

  9. De la Rosa Santana JD, Santiesteban Puerta S. Afectaciones oftalmológicas causadas por la infección del SARS-CoV-2. Rev cubana med. 2021 [acceso 24/03/2022];60(1):e1627. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232021000100001&lng=es9.

  10. Pérez-Bartolomé F, Sánchez-Quirós J. Manifestaciones oftalmológicas del SARS-CoV-2: Revisión de la literatura. Archivos de la Sociedad Española de Oftalmología. 2021 [acceso 24/03/2022];96(1):32-40. Disponible en: www.elsevier.es/oftalmologia12

  11. Quijano BA, Córdova CM. Pupila tónica después de la infección por COVID. Archivos de la Sociedad Española de Oftalmología. 2021. DOI: https://doi.org/10.1016/j.oftal.2021.01.00311. .

  12. García R, Nicholls B, Hernández-Tejero A, Fernández-de-Arévalo B. COVID-19 asociada a nistagmo. Archivos de la Sociedad Española de Oftalmología. 2021;96(4):224-6.

  13. Chen L, Liu M, Zhang Z. Ocular manifestations of a hospitalized patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020;104(6):748-75. DOI: http://dx.doi.org/10.1136/bjophthalmol-2020-31630413.

  14. Rahib D. Manifestaciones Oftalmológicas en Pacientes con COVID 19. Gac Med Bol. 2021,44(2). DOI: https://doi.org/10.47993/gmb.v44i2.31614.

  15. Márquez M, Cáceres M, Cáceres O. Enfermedades adquiridas del nervio óptico. En: Manual de Prácticas Médicas del Hospital Clínico-Quirúrgico "Hermanos Ameijeiras". 5ta. Ed. La Habana: Hospital Clínico Quirúrgico Hermanos Ameijeiras. 2020:1-15.

  16. Maryam S, Abrishami M, Zamani G, Hemmati A, Momtahen S, Omidtabrizi A. Acute Bilateral Neuroretinitis and Panuveitis in A Patient with Coronavirus Disease. A Case Report. Ocul Immunol Inflamm. 2021;29(4):677-80. DOI: http://dx.doi.org/10.1080/09273948.2021.189445716.

  17. Poursadeghfarda M, Sharifian-Dorchea M, Nematic A, Ashkan Mowlad A. Simultaneous Encephalitis and Neuroretinitis After COVID-19 in a Young Adult: A Case Report. Journal of Neurology Research. 2021;11(5):102-7. DOI: https://doi.org/10.14740/jnr69817.

  18. Mowla A, Sizdahkhani S, Sharifian-Dorche M, Selvan P, Emanuel BA, Tenser MS, et al. Unusual pattern of arterial macrothrombosis causing stroke in a young adult recovered from COVID-19. J Stroke Cerebrovasc Dis. 2020;29(12):105353. DOI: http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2020.10535318.

  19. Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini PS, et al. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci. 2020;417. DOI: http://dx.doi.org/10.1016/j.jns.2020.11708519.

  20. Romero-Sanchez CM, Diaz-Maroto I, Fernandez-Diaz E, Sanchez-Larsen A, Layos-Romero A, Garcia-Garcia J, et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020;95(8):e1060-e1070. DOI: http://dx.doi.org/10.1212/WNL.000000000000993720.

  21. Sim R, Cheung G, Ting D, Wong E, Wong TY, Yeo I, et al. Retinal microvascular signs in COVID-19. Br J Ophthalmol. 2021. DOI: http://dx.doi.org/10.1136/bjophthalmol-2020-3182362221.

  22. Liu L, Zhen HM, Shen Y. COVID-2019 associated with acquired monocular blindness: could be central artery occlusion or viral uveitis? Curr Eye Res. 2021:1-2. DOI: http://dx.doi.org/10.1080/02713683.2021.192932722.

  23. Hosseini SM, Abrishami M, Zamani G, Hemmati A, Momtahen S, Hassani M, et al. Acute bilateral neuroretinitis and panuveitis in a patient with coronavirus disease 2019: a case report. Ocul Immunol Inflamm. 2021;29(4):677-680. DOI: http://dx.doi.org/10.1080/09273948.2021.189445723.

  24. Burgos-Blasco B, Guemes-Villahoz N, Vidal-Villegas B, Martinez-de-la-Casa JM, Donate-Lopez J, Martin-Sanchez FJ, et al. Optic nerve and macular optical coherence tomography in recovered COVID-19 patients. Eur J Ophthalmol. 2022;32(1):628-36. DOI: http://dx.doi.org/10.1177/1120672121100101924.

  25. Cáceres-Toledo O, Cáceres-Toledo M, Zhao R, Laurencio YC, O-Lozano YL, Díaz I. Unusual increase in the incidence of unilateral Optic Neuritis: Case presentation. J Clin Res Ophthalmol. 2021;8(2):044-8. DOI: https://dx.doi.org/10.17352/2455-1414.00009325.




2020     |     www.medigraphic.com